• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy & Understanding ALS/MND

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy & Understanding ALS/MND

Sep 24
1:00 pm - 2:00 pm EDT

Les Turner ALS Foundation: Cognitive and Language Impairments in ALS & ALS-FTD

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

View Calendar

  • Lombana, Spain

    Lombana, Spain

  • Daniel Hare, USA

    Daniel Hare, USA

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Len Johnrose, England

    Len Johnrose, England

  • Susan Keldani, USA

    Susan Keldani, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Jean

    Jean
    jean

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Greg Heydet, USA

    Greg Heydet, USA

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • David Watson, Scotland

    David Watson, Scotland

  • Jon Newsome, USA

    Jon Newsome, USA

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Olga, Argentina

    Olga, Argentina

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login